XML 42 R31.htm IDEA: XBRL DOCUMENT
v3.25.3

SEGMENT INFORMATION (Tables) | 9 Months Ended
--- | ---
Sep. 30, 2025
Segment Reporting [Abstract] |
SCHEDULE OF SEGMENT INFORMATION | SCHEDULE OF SEGMENT INFORMATION Goodwill and Assets
|  | NanoVibronix |  |  | ENvue |  |  | Corporate |  |  | Total |
Balance sheet at September 30, 2025: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Goodwill |  | $ | - |  |  | $ | 38,631 |  |  | $ | - |  |  | $ | 38,631 |
Assets |  | $ | 2,413 |  |  | $ | 51,970 |  |  | $ | - |  |  | $ | 54,383 |
Balance sheet at December 31, 2024: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Goodwill |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |
Assets |  | $ | 3,629 |  |  | $ | - |  |  | $ | - |  |  | $ | 3,629 |
Segment operating results
Nine months ended September 30, 2025: |  | NanoVibronix |  |  | ENvue |  |  | Corporate |  |  | Total |
Revenues |  | $ | 1,738 |  |  | $ | 503 |  |  | $ | - |  |  | $ | 2,241 |
Cost of revenues |  |  | 1,062 |  |  |  | 656 |  |  |  | - |  |  |  | 1,718 |
Research and development |  |  | 1,227 |  |  |  | 496 |  |  |  | - |  |  |  | 1,723 |
Selling and marketing |  |  | 756 |  |  |  | 1,122 |  |  |  | - |  |  |  | 1,878 |
General and administrative |  |  | 1,550 |  |  |  | 1,379 |  |  |  | 2,068 |  |  |  | 4,997 |
Total operating loss |  | $ | (2,857 | ) |  | $ | (3,150 | ) |  | $ | (2,068 | ) |  | $ | (8,075 | )
Nine months ended September 30, 2024: |  | NanoVibronix |  |  | ENvue |  |  | Corporate |  |  | Total |
Revenues |  | $ | 2,114 |  |  | $ | - |  |  | $ | - |  |  | $ | 2,114 |
Cost of revenues |  |  | 889 |  |  |  | - |  |  |  | - |  |  |  | 889 |
Research and development |  |  | 557 |  |  |  | - |  |  |  | - |  |  |  | 557 |
Selling and marketing |  |  | 545 |  |  |  | - |  |  |  | - |  |  |  | 545 |
General and administrative |  |  | 2,335 |  |  |  | - |  |  |  | - |  |  |  | 2,335 |
Total operating loss |  | $ | (2,212 | ) |  | $ | - |  |  | $ | - |  |  | $ | (2,212 | )
Three months ended September 30, 2025: |  | NanoVibronix |  |  | ENvue |  |  | Corporate |  |  | Total |
Revenues |  | $ | 371 |  |  | $ | 351 |  |  | $ | - |  |  | $ | 722 |
Cost of revenues |  |  | 187 |  |  |  | 346 |  |  |  | - |  |  |  | 533 |
Research and development |  |  | 44 |  |  |  | 177 |  |  |  | - |  |  |  | 221 |
Selling and marketing |  |  | 431 |  |  |  | 381 |  |  |  | - |  |  |  | 812 |
General and administrative |  |  | 323 |  |  |  | 577 |  |  |  | 503 |  |  |  | 1,403 |
Total operating loss |  | $ | (614 | ) |  | $ | (1,131 | ) |  | $ | (503 | ) |  | $ | (2,247 | )
Three months ended September 30, 2024: |  | NanoVibronix |  |  | ENvue |  |  | Corporate |  |  | Total |
Revenues |  | $ | 376 |  |  | $ | - |  |  | $ | - |  |  | $ | 376 |
Cost of revenues |  |  | 243 |  |  |  | - |  |  |  | - |  |  |  | 243 |
Research and development |  |  | 249 |  |  |  | - |  |  |  | - |  |  |  | 249 |
Selling and marketing |  |  | 181 |  |  |  | - |  |  |  | - |  |  |  | 181 |
General and administrative |  |  | 673 |  |  |  | - |  |  |  | - |  |  |  | 673 |
Total operating loss |  | $ | (970 | ) |  | $ | - |  |  | $ | - |  |  | $ | (970 | )
SUMMARY OF REVENUE WITHIN GEOGRAPHIC AREAS | The following is a summary of revenues within geographic areas: SUMMARY OF REVENUE WITHIN GEOGRAPHIC AREAS
|  | 2025 |  |  | 2024 |  |  | 2025 |  |  | 2024 |
|  | Three Months Ended September 30, |  |  | Nine Months Ended September 30, |
|  | 2025 |  |  | 2024 |  |  | 2025 |  |  | 2024 |
United States |  | $ | 694 |  |  | $ | 349 |  |  | $ | 2,133 |  |  | $ | 2,047 |
Europe |  |  | 8 |  |  |  | 8 |  |  |  | 25 |  |  |  | 8 |
Australia/New Zealand |  |  | 20 |  |  |  | 7 |  |  |  | 59 |  |  |  | 21 |
Other |  |  | - |  |  |  | 12 |  |  |  | 24 |  |  |  | 38 |
Total |  | $ | 722 |  |  | $ | 376 |  |  | $ | 2,241 |  |  | $ | 2,114 |

X
- Definition Tabular disclosure of revenue from external customers by geographic areas attributed to the entity's country of domicile and to foreign countries from which the entity derives revenue. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 41 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41 + Details
Name: | us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 25 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-25 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30 + Details
Name: | us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration